Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Scientific Reports|June 24, 2016
Oncogenic Sox2 regulates and cooperates with VRK1 in cell cycle progression and differentiationDavid S Moura, Isabel F Fernández, Gema Marín-Royo, et al.
International Journal of Molecular Sciences|June 27, 2020
Novel Dominant KCNQ2 Exon 7 Partial In-Frame Duplication in a Complex Epileptic and Neurodevelopmental Delay SyndromePedro A Lazo, Juan L García, Paulino Gómez-Puertas, et al.
Journal of Molecular Medicine (Berlin, Germany)|March 30, 2024
Pathogenic effects of Leu200Pro and Arg387His VRK1 protein variants on phosphorylation targets and H4K16 acetylation in distal hereditary motor neuropathyAurora Campos-Díaz, Patricia Morejón-García, Eva Monte-Serrano, et al.
Lung Cancer (Amsterdam, Netherlands)|August 11, 2007
Alteration of the VRK1-p53 autoregulatory loop in human lung carcinomasAlberto Valbuena, Ana Suárez-Gauthier, Fernando López-Rios, et al.
The Journal of Biological Chemistry|August 2, 2008
A central role for CK1 in catalyzing phosphorylation of the p53 transactivation domain at serine 20 after HHV-6B viral infectionNicola J MacLaine, Bodil Oster, Bettina Bundgaard, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 23, 2015
The spinal muscular atrophy with pontocerebellar hypoplasia gene VRK1 regulates neuronal migration through an amyloid-β precursor protein-dependent mechanismHadar Vinograd-Byk, Tamar Sapir, Lara Cantarero, et al.
Annals of Clinical and Translational Neurology|May 5, 2020
VRK1 (Y213H) homozygous mutant impairs Cajal bodies in a hereditary case of distal motor neuropathyAna T Marcos, Elena Martín-Doncel, Patricia Morejón-García, et al.
Seminars in Cancer Biology|March 2, 2010
Cancer as a reprogramming-like disease: implications in tumor development and treatmentAndrés Castellanos, Carolina Vicente-Dueñas, Elena Campos-Sánchez, et al.
Chemico-Biological Interactions|February 17, 2024
Loss of VRK1 alters the nuclear phosphoproteome in the DNA damage response to doxorubicinElena Navarro-Carrasco, Aurora Campos-Díaz, Eva Monte-Serrano, et al.
BMC Clinical Pathology|October 2, 2013
VRK2 identifies a subgroup of primary high-grade astrocytomas with a better prognosisIrene Rodríguez-Hernández, Marta Vázquez-Cedeira, Angel Santos-Briz, et al.
Pageof 8